BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26600440)

  • 1. Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.
    Basu A; Jenkins AJ; Zhang Y; Stoner JA; Klein RL; Lopes-Virella MF; Garvey WT; Lyons TJ;
    Atherosclerosis; 2016 Jan; 244():93-100. PubMed ID: 26600440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
    Lyons TJ; Jenkins AJ; Zheng D; Klein RL; Otvos JD; Yu Y; Lackland DT; McGee D; McHenry MB; Lopes-Virella M; Garvey WT;
    Diabet Med; 2006 Sep; 23(9):955-66. PubMed ID: 16922701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).
    Basu A; Jenkins AJ; Zhang Y; Stoner JA; Klein RL; Lopes-Virella MF; Timothy Garvey W; Lyons TJ;
    Data Brief; 2016 Mar; 6():33-8. PubMed ID: 26759826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes; 1999 Feb; 48(2):383-90. PubMed ID: 10334318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
    Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
    Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.
    Lyons TJ; Jenkins AJ; Zheng D; Lackland DT; McGee D; Garvey WT; Klein RL
    Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):910-8. PubMed ID: 14985310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D.
    Basu A; Jenkins AJ; Stoner JA; Zhang Y; Klein RL; Lopes-Virella MF; Garvey WT; Schade DS; Wood J; Alaupovic P; Lyons TJ;
    J Lipid Res; 2018 May; 59(5):872-883. PubMed ID: 29576550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis.
    Amor AJ; Catalan M; Pérez A; Herreras Z; Pinyol M; Sala-Vila A; Cofán M; Gilabert R; Ros E; Ortega E
    Atherosclerosis; 2016 Apr; 247():161-9. PubMed ID: 26921744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia.
    Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
    Diabetes Care; 2003 Mar; 26(3):810-8. PubMed ID: 12610042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study.
    Basu A; Jenkins AJ; Stoner JA; Thorpe SR; Klein RL; Lopes-Virella MF; Garvey WT; Lyons TJ;
    Atherosclerosis; 2014 Sep; 236(1):188-195. PubMed ID: 25063949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids and lipoprotein ratios: contribution to carotid intima media thickness in adolescents and young adults with type 2 diabetes mellitus.
    Shah AS; Urbina EM; Khoury PR; Kimball TR; Dolan LM
    J Clin Lipidol; 2013; 7(5):441-5. PubMed ID: 24079285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles.
    Amor AJ; Castelblanco E; Hernández M; Gimenez M; Granado-Casas M; Blanco J; Soldevila B; Esmatjes E; Conget I; Alonso N; Ortega E; Mauricio D
    Cardiovasc Diabetol; 2020 Aug; 19(1):126. PubMed ID: 32772924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
    Polak JF; Backlund JY; Cleary PA; Harrington AP; O'Leary DH; Lachin JM; Nathan DM;
    Diabetes; 2011 Feb; 60(2):607-13. PubMed ID: 21270271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses.
    Klein RL; Carter RE; Jenkins AJ; Lyons TJ; Baker NL; Gilbert GE; Virella G; Lopes-Virella MF;
    J Diabetes Complications; 2011; 25(2):73-82. PubMed ID: 20605479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of adolescent lipoprotein subclass profile with carotid intima-media thickness and comparison to adults: Prospective population-based cohort studies.
    Pechlaner R; Friedrich N; Staudt A; Gande N; Bernar B; Stock K; Kiechl SJ; Hochmayr C; Griesmacher A; Petersmann A; Budde K; Stuppner H; Sturm S; Dörr M; Schminke U; Cannet C; Fang F; Schäfer H; Spraul M; Geiger R; Mayr M; Nauck M; Kiechl S; Kiechl-Kohlendorfer U; Knoflach M;
    Atherosclerosis; 2022 Jan; 341():34-42. PubMed ID: 34995985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced lipoprotein profile identifies atherosclerosis better than conventional lipids in type 1 diabetes at high cardiovascular risk.
    Serés-Noriega T; Ortega E; Giménez M; Perea V; Boswell L; Mariaca K; Font C; Mesa A; Viñals C; Blanco J; Vinagre I; Pané A; Esmatjes E; Conget I; Amor AJ
    Nutr Metab Cardiovasc Dis; 2023 Jun; 33(6):1235-1244. PubMed ID: 37088651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes.
    Lopes-Virella MF; McHenry MB; Lipsitz S; Yim E; Wilson PF; Lackland DT; Lyons T; Jenkins AJ; Virella G;
    Atherosclerosis; 2007 Feb; 190(2):359-69. PubMed ID: 16530770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Prekallikrein Is Associated With Carotid Intima-Media Thickness in Type 1 Diabetes.
    Jaffa MA; Luttrell D; Schmaier AH; Klein RL; Lopes-Virella M; Luttrell LM; Jaffa AA;
    Diabetes; 2016 Feb; 65(2):498-502. PubMed ID: 26603531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes.
    Zhang Y; Jenkins AJ; Basu A; Stoner JA; Lopes-Virella MF; Klein RL; ; Lyons TJ
    J Lipid Res; 2016 Feb; 57(2):310-7. PubMed ID: 26658239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes.
    Lopes-Virella MF; Hunt KJ; Baker NL; Lachin J; Nathan DM; Virella G;
    Diabetes; 2011 Feb; 60(2):582-9. PubMed ID: 20980456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.